Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF)

Oral Oncology

Volumn 43, Issue 3, 2007, Pages 272-277

  Cho, Jae Hoon ^a   Kim, Hyung Seok ^b   Park, Chang Soo ^b   Kim, Jin Kook ^a   Jung, Kwang Yoon ^c   Shin, Bong Kyoung ^c   Kim, Han Kyum ^c  

^a Konkuk University School of Medicine   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Early oral tongue cancer; Maspin; Mutant type p53; Recurrence; VEGF

Indexed keywords

MASPIN; MUTANT PROTEIN; PROTEIN P53; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; SURVIVAL RATE; TONGUE CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SERPINS; TONGUE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846879161     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.03.018     Document Type: Article

References (20)

1. Reid B.C., Warren J.L., and Rozier G. Comorbidity and early diagnosis of head and neck cancer in a Medicare population. Am J Prev Med 27 (2004) 373-378
2. Gorsky M., Epstein J.B., Oakley C., Le N.D., Hay J., and Stevenson-Moore P. Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 546-552
3. Goto M., Hasegawa Y., Terada A., Hyodo I., Hanai N., Ijichi K., et al. Prognostic significance of late cervical metastasis and distant failure in patients with stage I and II oral tongue cancers. Oral Oncol 41 (2005) 62-69
4. Okamoto M., Nishimine M., Kishi M., Kirita T., Sugimura M., Nakamura M., et al. Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue. J Oral Pathol Med 31 (2002) 227-233
5. Hogmo A., Kuylenstierna R., Lindholm J., and Munck-Wikland E. Predictive value of malignancy grading systems, DNA content, p53, and angiogenesis for stage I tongue carcinomas. J Clin Pathol 52 (1999) 35-40
6. Hannen E.J., van der Laak J.A., Manni J.J., Pahlplatz M.M., Freihofer H.P., Slootweg P.J., et al. Improved prediction of metastasis in tongue carcinomas, combining vascular and nuclear tumor parameters. Cancer 92 (2001) 1881-1887
7. Shpitzer T., Chaimoff M., Gal R., Stern Y., Feinmesser R., and Segal K. Tumor angiogenesis as a prognostic factor in early oral tongue cancer. Arch Otolaryngol Head Neck Surg 122 (1996) 865-868
8. Mineta H., Miura K., Ogino T., Takebayashi S., Misawa K., and Ueda Y. Vascular endothelial growth factor (VEGF) expression correlates with p53 and ki-67 expressions in tongue squamous cell carcinoma. Anticancer Res 22 (2002) 1039-1044
9. Yasumatsu R., Nakashima T., Hirakawa N., Kumamoto Y., Kuratomi Y., Tomita K., et al. Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck 23 (2001) 962-966
10. Leedy D.A., Trune D.R., Kronz J.D., Weidner N., and Cohen J.I. Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. Otolaryngol Head Neck Surg 111 (1994) 417-422
11. Gleich L.L., Biddinger P.W., Duperier F.D., and Gluckman J.L. Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: a clinical-pathologic correlation. Head Neck 19 (1997) 276-280
12. Tokino T., and Nakamura Y. The role of p53-target genes in human cancer. Crit Rev Oncol Hematol 33 (2000) 1-6
13. Huang Z., and Bao S.D. Roles of main pro- and anti-angiogenic factors in tumor angiogenesis. World J Gastroenterol 10 (2004) 463-470
14. Rosenstein J.M., and Krum J.M. New roles for VEGF in nervous tissue-beyond blood vessels. Exp Neurol 187 (2004) 246-253
15. Zelzer E., and Olsen B.R. Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Top Dev Biol 65 (2005) 169-187
16. Shi H.Y., Zhang W., Liang R., Kittrell F., Templeton N.S., Medina D., et al. Modeling human breast cancer metastasis in mice: maspin as a paradigm. Histol Histopathol 18 (2003) 201-206
17. Sheng S. The promise and challenge toward the clinical application of maspin in cancer. Front Biosci 9 (2004) 2733-2745
18. Zou Z., Gao C., Nagaich A.K., Connell T., Saito S., Moul J.W., et al. p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 275 (2000) 6051-6054
19. Zhang M., Volpert O., Shi Y.H., and Bouck N. Maspin is an angiogenesis inhibitor. Nat Med 6 (2000) 196
20. Marioni G., Blandamura S., Giacomelli L., Calgaro N., Segato P., Leo G., et al. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx. Histopathology 46 (2005) 576-582